• ForwardForward
  • PrintPrint
  • Find EmployeesFind Employees
  • Find CompetitorsFind Competitors

Genpharm Inc.

85 Advance Road
Etobicoke, Ontario M8Z 2S6
Canada 
Website:  www.genpharm.ca
Phone:  (416) 236-2631
Fax:  (416) 236-9878
Genpharm's profile was created using:
  • 580 online sources
-

Summary

Industry:  Pharmaceuticals, Drug Manufacturing & Research
Revenues:  $74.9 Million
Employees:  600

Description
From its modest beginnings in 1983 as an R&D facility, Genpharm has grown to be one of Canada's top 20 pharmaceutical companies. Today, Genpharm ULC is a leading manufacturer of generic pharmaceuticals, with prescription products encompassing all major therapeutic classes. Genpharm's Hospital Division supplies an expanding range of equipment and pharmaceuticals for renal dialysis and is quickly becoming recognized as a leader in this field. At Genpharm we have built our business on the premise that people matter; and that success comes from paying attention to the people that really make a difference -- our customers, employees, and partners. In doing so, we strive to be your pharmaceutical company of choice.

-

Additional Resources

News Archive
Hoffmann-La Roche discontinues accutane sales.(PIPELINE PREVIEWS)
Journal of Drugs in Dermatology; 9/1/2009
...isotretinoin will still continue to be available from several manufacturers. These manufacturers include Barr Laboratories Inc., Genpharm Inc., Mylan Pharmaceuticals Inc. and Ranbaxy Laboratories Inc. Hoffman-La Roche, Inc. has noted declining sales to... ...more

Par Pharmaceutical Generics Company Intelligence Report - Available Today.
M2 Presswire; 7/21/2009
...branded pharmaceuticals for specialty markets. Many products are licensed-in from other generic manufacturers, such as Genpharm or Spectrum, or originator companies. Par has concluded a number of authorised generic agreements with originators. Par... ...more

Medarex Partners With Pfizer In Potential $510M Antibody Deal.
BIOWORLD Today; 11/3/2009
...10-year term of the collaboration. Medarex acquired its UltiMAb technology in 1997 through its $65 million purchase of Genpharm International Inc. It now has nearly 50 partners surrounding the UltiMAb technology. "It enables us to create fully human... ...more

Powered By:

-

Competitors

About Thumbshots thumbnails

Copyright © 2009 Zoom Information Inc. All rights reserved.

BBeachHead-2009-11-09_RC001.1 OM14